Sangamo BioSciences Income Statement
View: Annual | Quarterly
This data is provided as per license from EDGAR Online
| Dec 07 | Dec 06 | Dec 05 | |
|---|---|---|---|
| Revenue | 9.1 | 7.9 | 2.5 |
| Cost of Goods Sold | -- | -- | -- |
| Gross Profit | -- | -- | -- |
| Gross Profit Margin | 0.0% | 0.0% | 0.0% |
| SG&A Expense | 35.7 | 29.3 | 15.7 |
| Depreciation & Amortization | (1.9) | (0.7) | 0.5 |
| Operating Income | (24.8) | (20.7) | (13.8) |
| Operating Margin | -- | -- | -- |
| Nonoperating Income | 3.3 | 2.9 | 0.5 |
| Nonoperating Expenses | -- | -- | -- |
| Income Before Taxes | (21.5) | (17.9) | (13.3) |
| Income Taxes | -- | -- | -- |
| Net Income After Taxes | (21.5) | (17.9) | (13.3) |
| Continuing Operations | (21.5) | (17.9) | (13.3) |
| Discontinued Operations | -- | -- | -- |
| Total Operations | (21.5) | (17.9) | (13.3) |
| Total Net Income | (21.5) | (17.9) | (13.3) |
| Net Profit Margin | -- | -- | -- |
| Diluted EPS from Total Net Income ($) | (0.58) | (0.55) | (0.51) |
| Dividends per Share | -- | -- | -- |
This data is provided as per license from EDGAR Online
